1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsI-Corps: Translational Potential of Cryobioprinting Tissues in Drug Screening and Development is sponsored by National Science Foundation (NSF). Focuses on developing shelf-stable, ready-to-use 3D bioprinted tissue models for preclinical drug development.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
I-Corps: Translational Potential of Cryobioprinting Tissues in Drug Screening and Development - National Science Foundation I-Corps: Translational Potential of Cryobioprinting Tissues in Drug Screening and Development This I-Corps project focuses on the development of shelf-stable, ready-to-use 3D bioprinted tissue models for preclinical drug development.
Current in vitro models, such as 2D cultures, spheroids, and organoids, are useful in certain contexts but the structural and cellular complexity need to more accurately replicate human physiology. As a result, the printed tissue models often fail to predict clinical outcomes, contributing to high drug attrition rates.
Regulatory trends increasingly favor alternatives to animal models, highlighting the urgent need for advanced, human-relevant in vitro systems. While 3D bioprinting offers a path forward, its impact has been limited by the inability to store, manufacture centrally, and distribute models. Cryobioprinted tissues address these challenges by enabling long-term storage and on-demand use.
This advancement improves accessibility, reproducibility, and scalability for applications such as drug screening, toxicity testing, and disease modeling. This I-Corps project utilizes experiential learning coupled with a first-hand investigation of the industry ecosystem to assess the translation potential of the technology.
This solution is based on cryobioprinting, a method that combines 3D bioprinting with integrated cryopreservation during biofabrication. The resulting constructs can be frozen, stored, shipped, and thawed while maintaining structural integrity and biological function. The platform supports diverse cell types and applications, including personalized medicine.
In addition to supporting drug development workflows, the technology improves efficiency, accelerates timelines, and aims to enhance predictive accuracy while reducing overall drug development costs. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
NSF Program Director: Ruth Shuman Status Active Effective start/end date 09/15/25 → 08/31/26 I-Corps Teams: $50,000. 00 Biotechnology - Other than SynBio Genomics and bioinformatics Congressional District at Award District n. 07 of Massachusetts Current Congressional District District n.
07 of Massachusetts Core Based Statistical Area (CBSA) Boston-Cambridge-Newton, MA-NH https://www. nsf. gov/awardsearch/showAward?
AWD_ID=2544218
According to the current listing, eligibility includes: U. S. organizations, including for-profit entities. Confirm the full requirements in the official notice before applying.
The current listing shows $50,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was August 31, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
I-Corps: Translational Potential of Cryobioprinting Tissues in Drug Screening and Development is funded by National Science Foundation (NSF). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
MGPV Travel Grant is sponsored by Geological Society of America (GSA), Mineralogy, Geochemistry, Petrology, Volcanology Division. MGPV Travel grants support student travel to the annual GSA meeting. Applications are restricted to active graduate or undergraduate students who are the presenting authors of an accepted abstract at the annual GSA meeting.
Research Opportunities in Space and Earth Science (ROSES) - 2025: A.4 Rapid Response and Novel Research in Earth Science is sponsored by National Aeronautics and Space Administration (NASA) Science Mission Directorate (SMD). This omnibus research funding opportunity includes various program elements, with rolling submissions for Earth Science research through August 2026. Proposers to Earth Science using the NASA Center for Climate Simulation high-end computing facility must include specific budget details.
TCUP lists eight funding tracks and roughly $10.3M a year, but the October 14, 2026 deadline applies to only three of them — CHAI, Pre-TI, and TCUP Partnerships — and each carries a restriction that disqualifies most applicants. Here is the track-by-track math.
Read articleNSF 26-513 makes roughly $100 million available for up to 10 State and Regional AI Infrastructure Hubs at $4M to $12M each over five years. One award per state or multi-state region. One proposal per organization. And NSF is not buying you GPUs — it funds the coordination, the workforce and the faculty training, while the compute has to come from partners you have to already have.
Read articleAs of September 12, NSF had obligated $6.3 billion across 6,200 grants versus $8.1 billion and 8,600 last year. AHRQ has made 61 awards. Judge Allison Burroughs ordered the government to report by September 28 on whether IES will obligate $180 million before it expires. Here is what actually happens to the money on October 1 — and what it means for your FY2027 application.
Read article